Results 301 to 310 of about 475,791 (348)

The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials

British Journal of Cancer, 2020
Giovanni Fucà, Roberto Moretto, Salvatore Corallo   +2 more
exaly  

FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study

Lancet Oncology, The, 2015
Chiara Cremolini, Fotios Loupakis, Sara Lonardi   +2 more
exaly  

Lost Tribes

2018
openaire   +1 more source

Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial

Lancet Oncology, The, 2020
Chiara Cremolini, Daniele Rossini, Sara Lonardi   +2 more
exaly  

Tribe Apolysini, new tribe

1989
openaire   +1 more source

A chromosome conformation capture ordered sequence of the barley genome

Nature, 2017
Martin Mascher, Heidrun Gundlach, Axel Himmelbach   +2 more
exaly  

Tribe Usiini, new tribe

1989
openaire   +1 more source

Making Mosquito Taxonomy Useful: A Stable Classification of Tribe Aedini that Balances Utility with Current Knowledge of Evolutionary Relationships

PLoS ONE, 2015
Yvonne-Marie Linton, Dina M. Fonseca, Ted R Schultz   +2 more
exaly  

Tribes

2019
openaire   +2 more sources

TRIBE: Hijacking an RNA-Editing Enzyme to Identify Cell-Specific Targets of RNA-Binding Proteins

Cell, 2016
Aoife C Mcmahon, Reazur Rahman, Hua Jin
exaly